CORDIS - EU research results
CORDIS

Enhanced cybersecurity for networked medical devices through optimisation of guidelines, standards, risk management and security by design

Project description

Navigating the innovation regulatory frontiers in EU healthcare

In the pursuit of excellence in EU healthcare, outdated regulations impede the seamless integration of cutting-edge digital health innovations into clinical practice. The EU-funded CYMEDSEC project emerges as a beacon of progress, bridging the gap between rapid technological advancements and outdated regulations. Bringing together a consortium of regulatory, cybersecurity, and technology experts, the project is poised to revolutionise healthcare by fostering a dynamic interplay between novel technologies and regulatory frameworks, balancing safety with innovation. Focusing on the Internet of Medical Things (IoMT), CYMEDSEC enhances cybersecurity across multiple layers for remote patient monitoring ('hospital at home') and critical care. The project innovates via regulatory review, cybersecurity oversight, new standards, and a benefit-risk toolbox to drive a secure and competitive healthcare sector.

Objective

For the EU health industry to be competitive and to sustainably deliver internationally leading care quality, it is important that EU regulation, guidelines and standards enable effective and interoperable digital health innovation and promote a vibrant entrepreneurial EU sector. Safety and competitiveness are not mutually exclusive. To deliver on them requires a pace and intensity of technological innovation that is matched by intensive regulatory innovation. Smarter, adaptive, dynamic, and evidence-based regulatory approaches are needed, based on real world experience in representative use scenarios. CYMEDSEC has been designed with an optimum consortium of regulatory, cybersecurity, technology, evaluation, and clinical EU experts to address exactly this challenge. It provides close feedback loops between new technological paradigms and recommendation of regulatory approaches, fostering regulatory science fresh thinking.
It will deliver novel security-by-design solutions for the oversight of ‘Internet of Medical Things’ (IoMT) devices, including connected in vitro diagnostics. IoMT ‘fleet’ cybersecurity oversight systems will be developed. Use cases explored include remote patient monitoring and critical care scenarios, for which the project will develop novel and highly secure gateway middleware. Our technological and methodological advancement will go hand-in-hand with detailed review of regulations and guidelines, the formal creation of a new IoMT cybersecurity standard, and evidence collection from representative case studies. These objectives are holistically interlinked, with learnings form each work area feeding into development and proposals in other areas. Key to this is the in-project development of a cybersecurity benefit-risk toolbox, which will further develop the state of the art, using qualitative and quantitively approaches, and will make these available as easily usable and findable Open-Source resources for manufactures and regulatory bodies.

Coordinator

TECHNISCHE UNIVERSITAET DRESDEN
Net EU contribution
€ 1 553 125,00
Address
HELMHOLTZSTRASSE 10
01069 Dresden
Germany

See on map

Region
Sachsen Dresden Dresden, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 553 125,00

Participants (10)

Partners (1)